SCHEMBL95078

SCHEMBL95078

[CH2]c1ccc(C(=O)N2CCC(OCc3ccccc3F)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.49
PRMT6 Q96LA8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
LSS P48449 2/20 0.43
HSD11B1 P28845 4/20 0.43
SCN9A Q15858 1/20 0.42
RIPK1 Q13546 1/20 0.42
KMT2A Q03164 2/20 0.41
NAMPT P43490 1/20 0.41
GRIN2B Q13224 1/20 0.41
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96557 0.82 CYP2C9 (0.52) L3MBTL1ALDH1A1MAPTHPGDLMNA
SCHEMBL23365149 0.81 CARM1 (0.56) CARM1PRMT6ALDH1A1SCN9AKMT2A
SCHEMBL13539592 0.77 CARM1 (0.45) CARM1PRMT6ALDH1A1MAPTHPGD
SCHEMBL1582323 0.76 ALDH1A1 (0.46) CARM1PRMT6L3MBTL1ALDH1A1MAPT
SCHEMBL1582322 0.76 ALDH1A1 (0.46) CARM1PRMT6L3MBTL1ALDH1A1MAPT
SCHEMBL22265504 0.75 GPR119 (0.58) CARM1PRMT6MAPTKMT2AMEN1
SCHEMBL95384 0.73 HPGD (0.52) L3MBTL1ALDH1A1HPGDLMNAKMT2A
SCHEMBL7332875 0.73 CARM1 (0.69) CARM1PRMT6SCN9A
SCHEMBL305207 0.71 L3MBTL3 (0.49) L3MBTL1ALDH1A1LMNAHSD11B1KMT2A
SCHEMBL18615766 0.70 CARM1 (0.57) CARM1PRMT6L3MBTL1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
CN-101489555-A Nf-kappa OTSUKA PHARMA CO LTD (JP) 2009-07-22 CN disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB CARM1 977/4885PRMT6 673/4885L3MBTL1 1099/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CARM1 2494/4885PRMT6 1115/4885L3MBTL1 262/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CARM1 2494/4885PRMT6 1115/4885L3MBTL1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.